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February 2010532 Abstracts1.1-2.4; P  .0001). Independent predictors of stroke included CAS (OR
1.6; 95% CI,1.3-2.0; P  .0001) and symptomatic disease (OR, 2.4; 95%
CI, 1.9-3.0; P  .0001). Among subgroups according to neurologic pre-
sentation, regression showed that CAS significantly increased the odds of
stroke in asymptomatic patients (OR, 1.6; 95% CI, 1.2-2.0; P  .0003).
Among symptomatic patients, CAS increased the odds of in-hospital death
(OR, 3.0; 95% CI, 1.7-5.1; P .0001) and trended towards significance for
stroke (OR, 1.7; 95% CI, 1.0-2.8; P .0569); odds of stroke were lower in
2006 than in 2005 (OR, 0.6; 95% CI, 0.4-0.9; P  .009; Table, Fig).
Conclusions: Despite a 66% increase in CAS in 2006, no significant
improvement in mortality or stroke was observed in 2005. These rates
remained higher than CEA regardless of patient presentation. Resource
utilization as measured by charges and discharge disposition also favored
CEA.
Table. Univariate analysis of postprocedural mortality
and stroke
Patients Year
Crude in-hospital
mortality, %
Crude postprocedural
stroke, %
CAS CEA
P
(CAS vs CEA) CAS CEA
P
(CAS vs CEA)
All patients 2005-06 0.95 0.45 .0045 1.6 0.95 .0001
2005 0.93 0.45 .0391 1.8 1.0 .0081
2006 0.95 0.45 .0121 1.5 0.89 .0051
P (2005 vs
2006)
NS NS . . . NS NS . . .
Asymptomatic 2005-06 0.66 0.38 NS 1.4 0.86 .0005
2005 0.57 0.38 NS 1.5 0.88 .0129
2006 0.71 0.39 NS 1.3 0.83 .0176
P (2005 vs
2006}
NS NS . . . NS NS . . .
Symptomatic 2005-06 4.0 1.2 .0018 3.6 2.0 .0493
2005 4.6 1.4 .0235 4.1 2.5 NS
2006 3.5 1.0 .0293 3.2 1.5 NS
P (2005 vs
2006)
NS NS . . . NS .0181 . . .
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy; NS,
not significant.
Fig. A,Median hospital charges.B,Home discharges after carotid
revascularization. CAS, Carotid angioplasty and stenting; CEA,
carotid endarterectomy.Long-Term Outcome of Carotid Endarterectomy with Bovine Pericar-
dial Patch Closure: A Comparison to Dacron Patch and Primary
Closure
Karen J. Ho, and Matthew T. Menard, From Brigham and Women’s
Hospital, Boston, Mass
Objectives: Bovine pericardial patches (BPP) are increasingly used
during femoral and carotid endarterectomies (CEA), and owing to handling
and sonographic properties, have become our patch material of choice in
recent years. However, the long-term performance of this material com-
pared with other CEA closure strategies remains poorly defined. We sought
to determine how infection and bleeding complications after CEA per-
formed with BPP compared with CEA performed with Dacron patches or
primary closure (PC).
Methods: All consecutive CEA performed between January 1, 1996,
and December 31, 2008, at a single institution were entered real-time into a
relational database.
Results:During the 12-year study period, 1331 CEAs were performed
(Table).Mean follow-upwas 1412 days (median, 1147 days). There were no
statistically significant differences in the rates of postoperative wound infec-
tion, hematoma, stroke, or 30-day mortality in the three groups. Five-year
patency was significantly improved with BPP and Dacron patches compared
with PC. Five-year survival was also enhanced with BPP compared with
Dacron patches and PC.
Conclusions: In this nonconcurrent cohort study, which represents
the largest reported experience with BPP during CEA to date, the rate of
postoperative bleeding and infection complications with BPP was similar to
that with Dacron patching and PC. Beyond equivalent clinical performance,
our data suggest BPP is associated with increased long-term survival.
Stroke and Death after Carotid Endarterectomy and Carotid Artery
Stenting with and without Coronary Artery Bypass
Kristina A. Giles, Frank B. Pomposelli, Allen D. Hamdan, MarcWyers, and
Marc L. Schermerhorn, From Beth Israel Deaconess Medical Center. Bos-
ton, Mass
Objectives: By Centers for Medicare and Medicaid Services (CMS),
carotid artery stenting (CAS) patients are high surgical risk. We evaluated
mortality and stroke after CEA and CAS combined with and without
coronary artery bypass grafting/valve surgery (CABG/V) and adjusted for
medical high-risk criteria.
Methods: The Nationwide Inpatient Sample (2004-2006) was que-
ried by International Classification of Diseases, 9th Revision, codes for
CEA and CAS with diagnosis of carotid artery stenosis. CABG/V proce-
dures were also identified. Symptom status was defined by history of
stroke, transient ischemic attack (TIA), and/or amaurosis fugax. Post-
operative stroke was defined by coding for postoperative complications
(997.02).
Results: We identified 367,255 CEA (90%) and 40,404 CAS (10%).
CABG/V was performed more commonly with CEA than CAS (2.9% vs
1.0%, P .001). Demographics and comorbidities are summarized in Table
I. Patients undergoing CAS alone or CAS with CABG/V were more likely
symptomatic (13.6% vs 13.3%) than those undergoing CEA alone or CEA
with CABG/V (9.6% vs 6.9%; P .001 vs P .05). Mortality was 0.6% for
carotid intervention alone and 4.1% for tandem CABG/V (P  .001).
Stroke occurred in 1.0% of carotid procedures alone and in 3.4% of
CABG/V. Stroke or death was 1.4% for CEA vs 3.6% for CAS alone and
7.0% for CEA vs 11.4% for CAS with CABG/V. Multivariate predictors of
Table. Comparison of patch closure for carotid
endarterectomy
Outcome BPP Dacron PC P
(n  457) (n  642) (n  216)
Infection, No. (%) 3 (0.6) 2 (0.3) 0 (0) NS
Hematoma, No. (%) 16 (3.5) 21 (3.3) 5 (2.3) NS
Stroke, No. (%) 6 (1.3) 14 (2.2) 1 (0.5) NS
30-day mortality, No. (%) 6 (1.3) 5 (0.8) 0 (0) NS
5-year patency, % 98.9  0.6 98.0  0.6 94.8  1.6
BPP vs PC .005
Dacron vs PC .031
5-year survival, % 77.9  3.6 69.8  2.1 66.9  3.5
BPP vs Dacron .026
BPP vs PC .014
Continuous data are mean  standard deviation
BPP, Bovine pericardial patches; PC, primary closure.stroke or death included age, symptom status, congestive heart failure,
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 2 Abstracts 533chronic renal failure, chronic obstructive pulmonary disease, CABG/V, and
CAS (Table II). CAS carried a 2.5-fold increased risk of stroke or death vs
CEA.
Conclusions: CAS from 2004 to 2006 had a higher risk of stroke and
death than CEAwith and without CABG/V, even after adjustment for CMS
high-risk criteria. Further risk-adjusted prospective and randomized analyses
are needed before broad expansion of CAS.
Novel Implantable Vein Graft Contrast Yields Enhanced Outer Wall
Definition in Magnetic Resonance Imaging
C. Keith Ozaki, Dimitrios Mitsouras, Praveen K. Vemula, Dia Smiley,
Ming Tao, Peng Yu, Christina Campagna, Weian Zhao, Robert V.
Mulkern, Jeffrey Karp, and Frank Rybicki, From Brigham and Women’s
Hospital. Boston, Mass
Introduction: Emerging data support a role for negative wall remod-
eling in the failure of vascular interventions such as vein grafts, yet clinicians
and researchers currently lack the ability to temporally and efficiently inter-
rogate the adventitial surface topography and total vascular wall anatomy in
vivo. Our long-term goal is the development of an implantable contrast
material immobilized on the vein conduit outer surface ex vivo at the time of
operation that will allow high-throughput and spatial resolution vascular
wall imaging in vivo longitudinally. We hypothesized that commercially
available iron (Fe) magnetic nanoparticles can be covalently immobilized
onto the human vein graft wall and subsequently enable delineation of the
adventitia with magnetic resonance imaging (MRI).
Methods: Carboxy-modified Fe nanoparticles (30 nm) were activated
through N-hydroxysuccinimide ester, incubated on human vein adventitia
(covalently binds to amines), and thoroughly rinsed. Vein segments were
imaged on a 3T MRI system with proton-density, T2*, T1, inversion-
recovery contrasts. Histology served as the morphometric standard.
Results: The Fe nanoparticles induced a thin layer of negative contrast
Table I. Demographics and comorbidities
Variables CEA CAS Pa
Total patients, No (%) 367,255 (90.1) 40,404 (9.9)
With CABG/V 10,719 (2.9) 399 (1.0) .001
Without CABG/V 348,414 (97.1) 38,166 (99.0) .001
Age 80 y, % 16.8 17.5 .08
Female, % 42.6 39.8 .001
CHF, % 6.7 10.1 .001
Renal failure, % 4.0 6.8 .001
COPD, % 21.5 18.1 .001
Symptomatic, % 9.6 13.6 .001
With CABG/valve 6.9 13.3 .05
Without CABG/V 9.5 13.5 .001
Stroke or death, % 1.4 3.6 .001
With CABG/V 7.0% 11.4 .13
Without CABG/V 1.3% 3.5 .001
Mortality 0.6% 1.7 .001
With CABG/V 4.0% 6.4 .30
Without CABG/V 0.4% 1.7 .001
CABG/V, Coronary artery bypass grafting with valve surgery; CAS, carotid
artery stenting; CEA, carotid endarterectomy; CHF, congestive heart fail-
ure; COPD, chronic obstructive pulmonary disease.
aP  .05 is statistically significant.
Table II. Multivariate predictors of stroke or death
Predictor OR 95% CI Pa
Carotid artery stenting 2.5 2.2-2.8 .001
Symptomatic 7.1 6.3-8.0 .001
CABG/V (vs no cardiac procedure) 6.8 5.7-8.1 .001
Congestive heart failure 2.2 1.8-2.5 .001
Chronic renal failure 1.6 1.3-2.0 .001
COPD 1.2 1.05-1.4 .01
Age (by decade) 1.1 1.02-1.14 .05
Female gender 1.1 1.0-1.2 .19
CABG/V,Coronary artery bypass grafting with valve surgery;CI confidence
interval; COPD, chronic obstructive pulmonary disease; OR, odds ratio.
aP  .05 is statistically significant.that differentiated the adventitia from surrounding saline signal in all MRIs
(Fig A and B), enabling delineation of wall anatomy (C); this was notpossible in simultaneously imaged unlabeled control veins (D). Fe dose/
response was also observed (B, low [left] to high [right] dose).
Conclusions: Fe can be immobilized (dose-dependent) on human vein
for MRI detection, greatly enhancing subsequent delineation of total wall
anatomy. This novel imaging approach offers a potentially revolutionary
strategy for longitudinal enhancement of vascular biology imaging in vivo.
A Novel Cellular Model of Vein Graft Adaptation
Amanda Feigel, Akihito Muto, Tiffany Fancher, Mariangela Rivera,
Aaron Feinstein, Susun Kim, Yuka Kondo, and Alan Dardik, From Yale
University. New Haven, Conn
Introduction: Vein graft adaptation (VGA) is characterized by thick-
ening of the vein wall, a complex process involving cell proliferation and
migration. We have previously shown that VGA is also characterized by loss
of the venous determinant Eph-B4.We developed an in vitro model to study
molecular mechanisms that mediate VGA.
Methods: Aortic interposition grafts were examined using vein from
wild-type and Eph-B4 heterozygous knockout (Eph-B4-KO) mice. Endo-
thelial cells (EC) were isolated from wild-type and Eph-B4-KO mice. Cell
proliferation was directly counted. Quantitative polymerase chain reaction
(qPCR) was used to evaluate basal messenger RNA (mRNA) expression.
Western blot was used to evaluate protein levels. Under basal and Ephrin-
B2/Fc-stimulated conditions, angiogenic tube formation was measured by
tube formation assay, cell migration was evaluated using a Boyden chamber,
and nitric oxide (NO) production was evaluated fluorometrically.
Results: Vein grafts from Eph-B4-KO mice had 50% increased neoin-
timal thickness vs wild-type vein grafts (P  .01). Under basal conditions,
Eph-B4-KO cells proliferated 41% more slowly than wild-type EC (P 
.029) and 43% more slowly when stimulated with Ephrin-B2/Fc. Basal
levels of Akt were 29% higher, and vascular endothelial growth factor
(VEGF) was 28% lower in Eph-B4-KO cells vs wild-type EC. Under direct
stimulation, levels of phosphorylated Akt were 31% greater and levels of
phosphorylated extracellular signal-regulated kinase 1/2 were 12% greater
in Eph-B4-KO cells vs wild-type cells. QPCR confirmed 49% less VEGF-A
mRNA expression in Eph-B4-KO cells. Eph-B4-KO cells had 87% greater
angiogenic tube formation (P .001) and 14% greater NO production (P
.0092) under stimulated conditions. Eph-B4-KO cells had 60% reduced cell
migration in response to Ephrin-B2/Fc (P  .005).
Conclusions: EC isolated from Eph-B4-KO mice is a novel in vitro
cellular model of VGA. This model suggests that reduced Eph-B4 expres-
sion during VGA may be mediated by upstream signals such as VEGF-A as
well as downstream signal pathways such as Akt.
Divergent Systemic and Local Inflammatory Response to Hind Limb
Demand Ischemia in Wild-Type and Hypercholesterolemic Mice
Robert S. Crawford, Hassan Albadawi, Alessandro Robaldo, Christo-
pher J. Abularrage, Hyung-Jin Yoo, Michael A. Peck, and Michael T.
Watkins, From Massachusetts General Hospital. Boston, Mass
Fig. A, Fe nanoparticles induced a layer of negative contrast in
magnetic resonance imaging (MRI) that differentiated the adven-
titia from surrounding saline. B, Fe dose/response from low to
high is shown left to right. MRI showed wall anatomy in (C)
Fe-labeled vein but (D) not in unlabeled control veins (D).Introduction: In patients with peripheral vascular disease, claudication
is a frequent symptom related to skeletal muscle demand ischemia. These
